Abstracts of the 9th Congress of the
European Society of Contraception
|
|||
3-6 MAY 2006 ISTANBUL/ TURKEY |
|||
1 | Non-contraceptive benefits of contraceptives | 9 | Emergency contraception |
2 | Hormonal contraception | 10 | Complications of oral contraceptives |
3 | Counselling for contraception | 11 | IUDs |
4 | Adolescent contraception | 12 | Contraception and infections |
5 | Cancer and contraception | 13 | Sexual and Reproductive Health Services |
6 | New contraceptive methods | 14 | Sexual Health Education for young people |
7 | Abortion | 15 | Quality in reproductive health services |
8 | Male contraception | 16 | Other topics |
P001 | NuvaRing® improves quality of life-results from a clinical experience program in Spain | Abstract |
I Lete Lasa Hospital Santiago Apóstol, Gynecology Department, Vitoria, Spain |
||
P002 | The benefits of contraceptives in the management of menstrual migraine | Abstract |
A MacGregor The City of London Migraine Clinic, London, United Kingdom |
||
P003 | NuvaRing® has a beneficial effect on acne-results from a clinical experience program in Spain | Abstract |
I Lete Lasa Santiago Apóstol Hospital, Gynecology Department, Vitoria, Spain |
||
P004 | An investigation into subjective well-being during oral contraceptive
(Mercilon®) use |
Abstract |
T Fel1, J Almasi1, I Szabo2 1Organon Hungary Ltd, Medical Department, Budapest, Hungary, 2Medical School of the University of Pecs, Clinical Department of Obstetrics and Gynaecology, Pecs, Hungary |
||
P005 | Improvement of dysmenorrhoea and premenstrual syndrome in
NuvaRing® users-a clinical experience program in Spain |
Abstract |
I Lete Lasa Santiago
Apóstol Hospital, Gynecology Department, Vitoria, Spain |
||
P006 | The impact of an oral contraceptive containing
ethinyl estradiol and drospirenone on the quality of life in young women |
Abstract |
K. Sedlecki, I. Mazibrada, Z.
Stankovic, S. Perovic Family PlanningCenter, Mother and Child Health Care Institute of Serbia, Belgrade, United States |
||
P007 | Continuation rates of levonorgestrel intrauterine
device(Mirena) inserted for non-contraceptive reasons after 6 months use |
Abstract |
A.K. Abraham, S Radhakrishnan Royal
Free Hospital, London,, United Kingdom |
||
P008 | Using Drosperinon-containing contraceptive by women with
hyperandrogenia |
Abstract |
L. Karakhalis, O. Fedorovich, N. Kovtun Kuban Medical University, Krasnodar, Russia |